Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway

Saved in:
Bibliographic Details
Published in:Analytical Cellular Pathology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301675025301507
collection WordPress RSS
FRELIP Feed Integration
container_title Analytical Cellular Pathology
description
discipline_display Pathology
discipline_facet Pathology
format Online Article
RSS Article
genre Journal Article
id rss_article:60311
institution FRELIP
journal_source_facet Analytical Cellular Pathology
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
Pathology
General
Pathology
sub_discipline_display General
sub_discipline_facet General
subject_display Pathology
General
Pathology
Pathology
General
Pathology
subject_facet Pathology
General
Pathology
title Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
title_auth Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
title_full Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
title_fullStr Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
title_full_unstemmed Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
title_short Xinlikang Capsule Alleviates Chemotherapy-Induced Fatigue by Inhibiting the PI3K/AKT-mTOR-FoxO Pathway
title_sort xinlikang capsule alleviates chemotherapy-induced fatigue by inhibiting the pi3k/akt-mtor-foxo pathway
topic Pathology
General
Pathology
url https://www.hindawi.com/journals/acp/2026/8879160/